Analysed ARRIVENT BIOPHARMA INC (AVBP:NASDAQ) News Sources
Wall Street Analysts Think ArriVent BioPharma, Inc. (AVBP) Could Surge 72.44%: Read This Before Placing a Bet
06-04-2026
yahoo.com
Assessing ArriVent BioPharma (AVBP) Valuation After Recent Share Price Momentum And Pipeline Interest
05-04-2026
yahoo.com
Aarvik Therapeutics Showcases Novel ADC Molecules Based On MUTTA™ and AQUALINK™ Platforms at AACR 2026
17-03-2026
yahoo.com
ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting
17-03-2026
yahoo.com
Wall Street Analysts See a 70.37% Upside in ArriVent BioPharma, Inc. (AVBP): Can the Stock Really Move This High?
10-03-2026
yahoo.com
Is ArriVent BioPharma, Inc. (AVBP) Stock Outpacing Its Medical Peers This Year?
10-03-2026
yahoo.com
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
11-02-2026
yahoo.com
What is the current price of ARRIVENT BIOPHARMA INC (AVBP:NASDAQ)?
The current price of ARRIVENT BIOPHARMA INC (AVBP:NASDAQ) is $25.47.
ARRIVENT BIOPHARMA INC (AVBP:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARRIVENT BIOPHARMA INC (AVBP:NASDAQ) since the previous trading day is $-1.78.
ARRIVENT BIOPHARMA INC (AVBP:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARRIVENT BIOPHARMA INC (AVBP:NASDAQ) since the previous trading day is -6.5321%.
What is the most recent average sentiment score for ARRIVENT BIOPHARMA INC (AVBP:NASDAQ)?
The most recent average sentiment score for ARRIVENT BIOPHARMA INC (AVBP:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for ARRIVENT BIOPHARMA INC (AVBP:NASDAQ)?
The most recent sentiment for ARRIVENT BIOPHARMA INC (AVBP:NASDAQ) is .
SEC-8K** Filing Available For ARRIVENT BIOPHARMA INC (AVBP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.